NDUFS8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.991800E-01
Normal-vs-Stage2
3.416200E-01
Normal-vs-Stage3
8.622400E-01
Normal-vs-Stage4
6.451400E-01
Stage1-vs-Stage2
8.276400E-01
Stage1-vs-Stage3
2.536600E-01
Stage1-vs-Stage4
1.147040E-01
Stage2-vs-Stage3
1.770780E-01
Stage2-vs-Stage4
1.480550E-01
Stage3-vs-Stage4
9.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.461000E-01
Normal-vs-AfricanAmerican
4.227400E-01
Normal-vs-Asian
1.062350E-01
Caucasian-vs-AfricanAmerican
9.394400E-01
Caucasian-vs-Asian
4.996000E-02
AfricanAmerican-vs-Asian
1.765810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.510200E-01
Normal-vs-Female
3.226000E-01
Male-vs-Female
6.407200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.329600E-01
Normal-vs-Age(41-60Yrs)
2.956200E-01
Normal-vs-Age(61-80Yrs)
3.927200E-01
Normal-vs-Age(81-100Yrs)
1.026160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.954600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.130400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.120800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.944400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.076400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.421200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.255600E-01
Normal-vs-Daily Drinker
1.604400E-01
Normal-vs-Weekly Drinker
1.408640E-01
Normal-vs-Occasional Drinker
3.651000E-01
Normal-vs-Social Drinker
3.040200E-01
Non Drinker-vs-Daily Drinker
3.511900E-02
Non Drinker-vs-Weekly Drinker
3.351800E-02
Non Drinker-vs-Occasional Drinker
4.946200E-01
Non Drinker-vs-Social Drinker
3.746800E-01
Daily Drinker-vs-Weekly Drinker
3.828400E-01
Daily Drinker-vs-Occasional Drinker
2.513800E-01
Daily Drinker-vs-Social Drinker
3.534600E-01
Weekly Drinker-vs-Occasional Drinker
8.429700E-02
Weekly Drinker-vs-Social Drinker
1.281630E-01
Occasional Drinker-vs-Social Drinker
8.589400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.274600E-01
Normal-vs-Grade 2
4.616400E-01
Normal-vs-Grade 3
4.770600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.968200E-01
Grade 1-vs-Grade 3
7.979400E-01
Grade 1-vs-Grade 4
6.274600E-01
Grade 2-vs-Grade 3
8.093800E-01
Grade 2-vs-Grade 4
4.616400E-01
Grade 3-vs-Grade 4
4.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.205800E-01
Normal-vs-NonDiabetic
2.076800E-01
Diabetic-vs-NonDiabetic
1.754190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.615700E-03
Normal-vs-NoPancreatitis
3.502400E-01
Pancreatitis-vs-NoPancreatitis
1.300620E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.589200E-01
Normal-vs-N1
3.918600E-01
N0-vs-N1
1.011590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.892200E-01
Normal-vs-TP53-NonMutant
8.033200E-01
TP53-Mutant-vs-TP53-NonMutant
1.954000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
